1. Home
  2. DCOY vs SXTP Comparison

DCOY vs SXTP Comparison

Compare DCOY & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.00

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$2.20

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCOY
SXTP
Founded
N/A
2010
Country
United States
United States
Employees
11
3
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DCOY
SXTP
Price
$6.00
$2.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$30.00
$14.10
AVG Volume (30 Days)
14.2K
209.9K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.39
Revenue Next Year
N/A
$36.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.34
52 Week High
$9.09
$8.62

Technical Indicators

Market Signals
Indicator
DCOY
SXTP
Relative Strength Index (RSI) 55.86 54.42
Support Level $5.40 $1.27
Resistance Level $9.09 $2.58
Average True Range (ATR) 0.66 0.21
MACD -0.28 0.08
Stochastic Oscillator 35.72 91.67

Price Performance

Historical Comparison
DCOY
SXTP

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: